Delivery Order SPE2DR25D3014-SPE2DR26FP1CX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,874.64 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL formulations. This competitively awarded, firm fixed-price delivery order was executed on November 3, 2025, with an ultimate completion date of November 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract includes no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $6,819.78 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3ml quantities. This non-competitive, firm fixed-price delivery order was issued on November 12, 2025, with an ultimate completion date of November 13, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,855.50 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3ml configurations. This firm fixed-price, competitively awarded contract was executed on August 6, 2025, with an ultimate completion date of August 7, 2025, and represents a pharmaceutical delivery to support federal medical procurement needs. The work is being performed at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at approximately $12.3K to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3ml formulations. This competitively awarded, non-set-aside contract was executed on April 28, 2025, with an ultimate completion date of April 29, 2025, and is priced on a firm fixed-price basis. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $11,073.16 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3mL vials, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price delivery order is non-set-aside and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $18,920.72 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of November 4, 2025. The award leverages AmerisourceBergen's position as a prime vendor under the Defense Logistics Agency's Troop Support Medical indefinite delivery contract (SPE2DX), valued...
- The Defense Logistics Agency awarded a $17,890.25 delivery order to AmerisourceBergen Drug Corp for supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3mL formulations. This competitively awarded, firm fixed-price delivery order is set to be completed by November 14, 2025, and represents fulfillment under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $19,789.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL format. The contract, awarded on August 8, 2025, with an ultimate completion date of August 11, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a non-set-aside competitive award and is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $37,324.69 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL formulations. The award was issued on August 26, 2025, with an ultimate completion date of August 27, 2025, and represents a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $5,554.06 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3ml formulations. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, executing through November 13, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The...
- SPE2DR25D3014Indefinite Delivery Contract
- SPE2DR25D3014-SPE2DR26FP1CXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,923.60 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25–0.5 mg/dose pens in 3 mL formulation. The contract, which carries a firm fixed price structure with no set-aside designation, was competitively awarded on November 20, 2025, with an ultimate completion date of November 21, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling value and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for the Department of Defense's medical supply chain. The company maintains an extensive portfolio of federal contracts covering a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains, including diabetes medications, neurological treatments, and specialty medical commodities. This delivery order for Ozempic supports military healthcare programs and reflects AmerisourceBergen's established capability to meet federal procurement requirements through open competition for pharmaceutical products needed by the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.9k | 11/20/25 |